Jing'an also launched the "Quality Products Import Demonstration Zone", a strategic initiative aimed at strengthening its ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

What's more, 11 Fortune Global 500 pharmaceutical corporations – Johnson & Johnson, Roche, MSD, Pfizer, Novartis, Bayer, Sanofi, AstraZeneca, GSK, Eli Lilly and Novo Nordisk – will show their ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Wednesday, November 13, 2024, at 2 p.m. CET / 8 a.m. ET ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

MOST Asian markets rose with the dollar and bitcoin on Wednesday as traders await the outcome of the knife-edge US presidential election, with bets increasing on a Donald Trump victory as early ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...